{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:56:36Z","timestamp":1787313396140,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10792-019-01213-6","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T13:15:23Z","timestamp":1575292523000},"page":"553-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["99mTc-DTPA SPECT\/CT provided guide on triamcinolone therapy in Graves\u2019 ophthalmopathy patients"],"prefix":"10.1007","volume":"40","author":[{"given":"Dan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"issue":"8","key":"1213_CR1","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 ophthalmopathy. N Engl J Med 362(8):726\u2013738","journal-title":"N Engl J Med"},{"issue":"3","key":"1213_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.beem.2011.11.007","volume":"26","author":"PJ Dolman","year":"2012","unstructured":"Dolman PJ (2012) Evaluating Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab 26(3):229\u2013248","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1213_CR3","first-page":"324","volume":"21","author":"BD Tong","year":"2015","unstructured":"Tong BD et al (2015) MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy. Mol Vis 21:324\u2013334","journal-title":"Mol Vis"},{"issue":"1","key":"1213_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/thy.2013.0240","volume":"24","author":"F Menconi","year":"2014","unstructured":"Menconi F, Profilo MA, Leo M et al (2014) Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited. Thyroid 24(1):60\u201366","journal-title":"Thyroid"},{"key":"1213_CR5","first-page":"477","volume":"92","author":"GB Bartley","year":"1994","unstructured":"Bartley GB (1994) The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc 92:477\u2013588","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"1213_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K et al (2016) The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of graves\u2019 orbitopathy. Eur Thyroid J 5(1):9\u201326","journal-title":"Eur Thyroid J"},{"issue":"8","key":"1213_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br J Ophthalmol 73(8):639\u2013644","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1213_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4274\/tjo.93609","volume":"45","author":"E Savku","year":"2015","unstructured":"Savku E, G\u00fcnd\u00fcz K (2015) Diagnosis, follow-up and treatment results in thyroid ophthalmopathy. Turk J Ophthalmol 45(4):156\u2013163","journal-title":"Turk J Ophthalmol"},{"issue":"2","key":"1213_CR9","first-page":"2086","volume":"8","author":"Y Wu","year":"2015","unstructured":"Wu Y, Tong B, Luo Y, Xie G, Xiong W (2015) Effect of radiotherapy on moderate and severe thyroid associated ophthalmopathy: a double blind and self-controlled study. Int J Clin Exp Med 8(2):2086\u20132096","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"1213_CR10","first-page":"869","volume":"9","author":"YJ Wu","year":"2016","unstructured":"Wu YJ, Wei X, Xiao MY, Xiong W (2016) Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathy. Int J Ophthalmol 9(6):869\u2013875","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"1213_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","volume":"47","author":"MP Mourits","year":"1997","unstructured":"Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 47(1):9\u201314","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"1213_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1507\/endocrj.K10E-156","volume":"57","author":"S Tachibana","year":"2010","unstructured":"Tachibana S, Murakami T, Noguchi H, Noguchi Y, Nakashima A, Ohyabu Y, Noguchi S (2010) Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves\u2019 ophthalmopathy. Endocr J 57(10):853\u2013861","journal-title":"Endocr J"},{"issue":"1","key":"1213_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5603\/NMR.a2018.0005","volume":"21","author":"L\u00e1szl\u00f3 Galuska","year":"2018","unstructured":"Galuska L\u00e1szl\u00f3, Barna S\u00e1ndor K, Varga J\u00f3zsef, Garai Ildik\u00f3, Nagy Endre V (2018) The role of 99mTc-DTPA retrobulbar SPECT in staging and follow-up of Graves\u2019 orbitopathy. Nucl Med Rev 21(1):54\u201358","journal-title":"Nucl Med Rev"},{"issue":"12","key":"1213_CR14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/00006231-200212000-00010","volume":"23","author":"L Galuska","year":"2002","unstructured":"Galuska L, Leovey A, Szucs-Farkas Z, Garai I, Szabo J, Varga J, Nagy EV (2002) SPECT using 99mTc-DTPA for the assessment of disease activity in Graves\u2019 ophthalmopathy: a comparison with the results from MRI. Nucl Med Commun 23(12):1211\u20131216","journal-title":"Nucl Med Commun"},{"issue":"2","key":"1213_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/MNM.0b013e32835c19f0","volume":"34","author":"L Szabados","year":"2013","unstructured":"Szabados L, Nagy EV, Ujhelyi B, Urbancsek H, Varga J, Nagy E, Galuska L (2013) The impact of 99mTc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves\u2019 ophthalmopathy. Nucl Med Commun 34(2):108\u2013112","journal-title":"Nucl Med Commun"},{"issue":"5","key":"1213_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00006231-200505000-00003","volume":"26","author":"L Galuska","year":"2005","unstructured":"Galuska L, Leovey A, Szucs-Farkas Z, Szabados L, Garai I, Berta A, Balazs E, Varga J, Nagy EV (2005) Imaging of disease activity in Graves\u2019 orbitopathy with different methods: comparison of (m)Tc-DTPA and (m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores. Nucl Med Commun 26(5):407\u2013414","journal-title":"Nucl Med Commun"},{"key":"1213_CR17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","volume":"329","author":"RS Bahn","year":"1993","unstructured":"Bahn RS, Heufelder AE (1993) Pathogenesis of Graves\u2019 ophthalmopathy. N Engl J Med 329:1468\u20131475","journal-title":"N Engl J Med"},{"issue":"1","key":"1213_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1755-3768.2008.01171.x","volume":"87","author":"M Bordaberry","year":"2009","unstructured":"Bordaberry M et al (2009) Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves\u2019 ophthalmopathy. Acta Ophthalmol 87(1):58\u201364","journal-title":"Acta Ophthalmol"},{"key":"1213_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1442-9071.2010.02332.x","volume":"38","author":"AA Alkawas","year":"2010","unstructured":"Alkawas AA, Hussein AM, Shahien EA (2010) Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. Clin Exp Ophthalmol 38:692\u2013697","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"1213_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00417-012-2153-y","volume":"251","author":"SJ Lee","year":"2013","unstructured":"Lee SJ et al (2013) Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Graefes Arch Clin Exp Ophthalmol 251(1):261\u2013270","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-019-01213-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-019-01213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T19:18:17Z","timestamp":1606763897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-019-01213-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1007\/s10792-019-01213-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was supported by Hunan Provincial Natural Science Foundation (No.\u00a02019JJ80012).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}